Last deal

Amount

Series A

Stage

26.07.2024

Date

1

all rounds

date founded

Financing round

General

About Company
Shengbao Bio is committed to the development of novel live bacterial medications, leveraging gene circuits and precise regulation of gene.

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

Shengbao Bio is committed to the development of novel live bacterial medications, leveraging gene circuits and precise regulation of gene and payload expression.
Contacts

Financials

Funding Rounds
1
1

Number of Funding Rounds

Their latest funding was raised on 26.07.2024. Their latest investor Boehringer Ingelheim Venture Fund. Their latest round Series A

Date 
Funding Round 
Investors 
Money Raised 
Lead 
Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund invests in therapeutic biotechnology companies.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Venture Capital, Biotechnology, Financial Services

Location

Ingelheim am Rhein, Germany

count Of Investments

71

count Of Exists

7
Temasek Holdings

Temasek Holdings

Temasek Holdings is a venture capital firm that focuses on investing in pharmaceutical and healthcare sectors.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Health Care

Location

Singapore

count Of Investments

455

count Of Exists

49
Co-Investors
Investors
5
2

Number of lead investors

5

Number of investors

Investor 
Lead 
Round 
Partners 
Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund invests in therapeutic biotechnology companies.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Venture Capital, Biotechnology, Financial Services

Location

Ingelheim am Rhein, Germany

count Of Investments

71

count Of Exists

7
Fosun Health Capital

Fosun Health Capital

Fujian Capital New Drug Innovation Fund is a holding incubation model for new drug innovation.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Xuhui District, Shanghai, China

count Of Investments

8
Temasek Holdings

Temasek Holdings

Temasek Holdings is a venture capital firm that focuses on investing in pharmaceutical and healthcare sectors.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Health Care

Location

Singapore

count Of Investments

455

count Of Exists

49

Activity

Recent News
0